Latest From Biotech Now

Patent Docs Highlights the BIO IPDx Symposium

shutterstock_10020697

Patent Docs recently highlighted McDonnell Boehnen Hulbert & Berghoff’s (MBHB) panel at BIO’s IP and Diagnostics Symposium (IPDx).  Moderated by Donald Zuhn at MBHB, panelists from MBHB, Roche Diagnostics, and the USPTO discussed the impact of the Myriad decision on obtaining patent protection for genetic diagnostics.  The panel concluded the following: “While there was agreement that the Myriad holding is not limited to human DNA, there was spirited disagreement regarding its long-term impact on patents claiming naturally Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Michael J. Fox Foundation Launches $10 Million Edmond J. Safra Core Programs

Moving Inside the Beltway: Brief Health Roundup

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has committed up to $10 million to its next funding round for the Edmond J. Safra Core Programs for PD Research to prioritize research toward transformative treatments and a cure for Parkinson’s disease (PD). We invite qualified researchers to apply to the Edmond J. Safra Core Programs for PD Research: Rapid Response Innovation Awards: This program supports high-risk, high-reward projects with little-to-no existing preliminary data, but with potential to significantly Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

10 Reasons We Need Crop Biotechnology and GM Foods

GLP-cropped-300x248

“The web has become a sewer channeling scare mongering about crop biotechnology,” says Jon Entine, executive director of the Genetic Literacy Project (GLP), and a senior fellow at the Center for Health & Risk Communication and STATS (Statistical Assessment Service) at George Mason University. “We at the GLP have come to think that anti-biotech campaigners do not respond well to reasoned discussion and complex logic,” says Entine.  So, the GLP is launching a new project:  Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Investor Forum Veterans Moving Up with the Recent Biotech Deal Surge

150639480

As detailed in The New York Times, the potential for deal-making in the industry has resulted in a big surge in the biotech sector. According to the article, last month alone, seven companies completed I.P.O’s and at least five are lined up behind them. Furthermore, according to data provided by NASDAQ, all 16 of the biotechnology companies that have gone public this year are up 48 percent on average from their offering prices. In fact Read More >

Events  |  Leave a comment  |  Email This Post
Tags:

BioOhio Selects New Leadership

lewis-john250

John Lewis has been promoted to CEO of BioOhio, the biological sciences trade organization, recognized as BIO’s affiliated state organization in Ohio. John has been with BioOhio for the last twelve years and has been instrumental to its highly successful efforts to grow the biotech industry in the state. Earlier this year, BioOhio’s previous long-serving head, Tony Dennis, retired. Under Tony’s 11-year leadership, BioOhio helped elevate Ohio into top-tier ranks amongst virtually all bioscience industry Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: ,